NASDAQ:ALKS

New National Survey of People Living With Bipolar I Disorder Provides Insights Into Disease-Related Challenges and the Treatment Journey

Summary: 
- Respondents Reported Physical and Psychosocial Impacts of Living with Bipolar I Disorder and Side Effects of Medications Used to Treat the Disease -
- More Than Half of Respondents Reported Trying Five or More Medications During Their Treatment Journey -
- 80% of Respondents Agreed They Wished There Were Medication Options that Relieved Their Bipolar I Disorder Symptoms with Fewer Side Effects -
Press Release
- Respondents Reported Physical and Psychosocial Impacts of Living with Bipolar I Disorder and Side Effects of Medications Used to Treat the Disease -
- More Than Half of Respondents Reported Trying Five or More Medications During Their Treatment Journey -
- 80% of Respondents Agreed They Wished There Were Medication Options that Relieved Their Bipolar I Disorder Symptoms with Fewer Side Effects -

Alkermes Highlights Ongoing Investigational Immuno-oncology Clinical Trials

Multimedia with summary

Alkermes is committed to researching and developing potential new cancer treatment options that may help address unmet patient needs. Clinical trials are an important step in evaluating the safety and efficacy of potential treatments. Learn more about the ongoing clinical trial program for our investigational immuno-oncology candidate: https://bit.ly/3pl8pkG

Alkermes' Senior VP, Human Resources Celebrates Its Unique Culture

Multimedia with summary

Our culture is rooted in respect for all and an unwavering commitment to, and passion for, our work. Learn more about what makes Alkermes’ culture unique: https://bit.ly/3lHO4n8

Alkermes Spotlights Cancer Research

Multimedia with summary

While coping with the effects of cancer during the holidays is difficult, we find hope in the research work being done at Alkermes to help expand the future of cancer treatment for patients and their families.

Alkermes Has Launched Employee Resource Groups

Multimedia with summary

In the words of our CEO Richard Pops, diversity, inclusion & belonging are “integral to our company’s culture and success.” In 2020, we launched Employee Resource Groups with a common purpose of supporting and enhancing the inclusiveness of our company culture. Read more about our commitment to equity in our latest corporate responsibility report.

Our Collective Responsibility to Respond Effectively to the Climate Crisis

Multimedia with summary

On the heels of COP26, we’re reminded of our collective responsibility to respond effectively to the climate crisis.

Alkermes Celebrates National Family Caregivers Month

Multimedia with summary

November is National Family Caregivers Month and as we prepare for Thanksgiving, it is a perfect opportunity to express our sincerest gratitude to family caregivers. Caregivers are invaluable throughout a patient’s cancer journey, tirelessly providing support and care to their loved ones.

One Overdose Is Too Many

Multimedia with summary

While one overdose is one too many, we now mourn the loss of the 100,000+ Americans lost to this epidemic in just one year. We reaffirm our commitment to drive awareness and action to make change for people affected by addiction: https://bit.ly/3qTL4Yi

Alkermes in Action: Giving Tuesday

Multimedia with summary

This #GivingTuesday we recognize the many employees who take time to support members of our communities who are in need. More than 10 years ago, we launched Alkermes in Action, an annual employee volunteer program designed to support volunteer efforts within our local communities:

New Survey Provides Insights Into Drinking Behaviors During the Pandemic

Summary: 
- Nearly One in Five Respondents 21+ Reported Heavy Drinking* During the 30 Days Prior to the Survey -
 
- Many Respondents Who Reported Heavy Drinking* Weren't Aware of All Treatment Options for Alcohol Dependence -
Press Release
- Nearly One in Five Respondents 21+ Reported Heavy Drinking* During the 30 Days Prior to the Survey -
 
- Many Respondents Who Reported Heavy Drinking* Weren't Aware of All Treatment Options for Alcohol Dependence -

Pages

Subscribe to NASDAQ:ALKS